Karyopharm Therapeutics Inc. APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition
Karyopharm Therapeutics Inc. (KPTI) reported APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition of $12.00 thousand for the 12-month period ending 2011-12-31, per its 10-K filed 2014-03-21.
Discontinued › Shareholders' Equity
us-gaap:AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition · last filed 2014-03-21
- Karyopharm Therapeutics Inc. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2011 was $12.00K, a 1100.00% increase from fiscal 2010.
- Karyopharm Therapeutics Inc. apic, share-based payment arrangement, restricted stock unit, increase for cost recognition for fiscal 2010 was $1.00K.
| Period end | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition 12 month |
|---|---|
| 2011-12-31 | $12.00K 10-K · filed 2014-03-21 |
| 2010-12-31 | $1.00K 10-K · filed 2014-03-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |